 Sarah Clark
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 5 | 2025 | 169 | 2.400 |
Why?
| | Interleukin-10 | 5 | 2024 | 310 | 2.200 |
Why?
| | Killer Cells, Natural | 4 | 2020 | 469 | 1.820 |
Why?
| | Haemophilus influenzae | 4 | 2024 | 63 | 1.640 |
Why?
| | Pneumonia, Bacterial | 2 | 2024 | 117 | 1.540 |
Why?
| | Staphylococcus aureus | 2 | 2025 | 437 | 1.380 |
Why?
| | Staphylococcal Infections | 2 | 2025 | 392 | 1.330 |
Why?
| | Host-Pathogen Interactions | 5 | 2020 | 372 | 1.310 |
Why?
| | Listeria monocytogenes | 3 | 2019 | 121 | 1.210 |
Why?
| | Listeriosis | 3 | 2019 | 69 | 1.170 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 385 | 1.150 |
Why?
| | Prevotella melaninogenica | 1 | 2025 | 2 | 0.970 |
Why?
| | Bacteroidaceae Infections | 1 | 2025 | 9 | 0.960 |
Why?
| | Haemophilus Infections | 2 | 2024 | 41 | 0.900 |
Why?
| | Pneumococcal Infections | 2 | 2025 | 110 | 0.870 |
Why?
| | Phosphorylcholine | 3 | 2013 | 21 | 0.860 |
Why?
| | Haemophilus | 1 | 2024 | 7 | 0.860 |
Why?
| | Corynebacterium | 1 | 2024 | 49 | 0.850 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 42 | 0.850 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2024 | 47 | 0.810 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 348 | 0.730 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 120 | 0.700 |
Why?
| | Lipopolysaccharides | 3 | 2018 | 889 | 0.700 |
Why?
| | Bacteria | 2 | 2020 | 881 | 0.640 |
Why?
| | Interleukin-15 | 1 | 2019 | 101 | 0.600 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 41 | 0.560 |
Why?
| | Streptococcal Infections | 1 | 2020 | 151 | 0.560 |
Why?
| | STAT3 Transcription Factor | 1 | 2019 | 204 | 0.550 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 156 | 0.520 |
Why?
| | Interleukin-18 | 1 | 2018 | 236 | 0.510 |
Why?
| | Microbiota | 1 | 2024 | 767 | 0.480 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5887 | 0.470 |
Why?
| | Immune Evasion | 2 | 2013 | 63 | 0.470 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1126 | 0.470 |
Why?
| | Repressor Proteins | 1 | 2018 | 425 | 0.450 |
Why?
| | Mice | 10 | 2025 | 18048 | 0.410 |
Why?
| | Lung Diseases | 1 | 2020 | 794 | 0.410 |
Why?
| | Bacterial Proteins | 3 | 2025 | 911 | 0.380 |
Why?
| | Antibodies, Bacterial | 1 | 2013 | 146 | 0.380 |
Why?
| | Animals | 13 | 2025 | 37657 | 0.370 |
Why?
| | Adaptive Immunity | 1 | 2012 | 173 | 0.330 |
Why?
| | Lung | 5 | 2024 | 4134 | 0.330 |
Why?
| | Complement System Proteins | 1 | 2013 | 333 | 0.320 |
Why?
| | Epithelial Cells | 2 | 2025 | 1110 | 0.290 |
Why?
| | Mice, Knockout | 3 | 2024 | 3068 | 0.290 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4404 | 0.260 |
Why?
| | Neutrophils | 2 | 2024 | 1282 | 0.260 |
Why?
| | Disease Susceptibility | 2 | 2018 | 352 | 0.230 |
Why?
| | Bacterial Adhesion | 1 | 2024 | 103 | 0.210 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 263 | 0.210 |
Why?
| | Oropharynx | 1 | 2024 | 45 | 0.210 |
Why?
| | Neutrophil Infiltration | 1 | 2024 | 108 | 0.200 |
Why?
| | Heme | 1 | 2024 | 76 | 0.200 |
Why?
| | Prevotella | 1 | 2022 | 22 | 0.190 |
Why?
| | Neutrophil Activation | 1 | 2022 | 87 | 0.180 |
Why?
| | Iron | 1 | 2024 | 323 | 0.180 |
Why?
| | Humans | 13 | 2025 | 141187 | 0.170 |
Why?
| | Flow Cytometry | 2 | 2016 | 1197 | 0.170 |
Why?
| | Bacterial Vaccines | 1 | 2020 | 63 | 0.160 |
Why?
| | Malaria, Cerebral | 1 | 2019 | 4 | 0.160 |
Why?
| | STAT4 Transcription Factor | 1 | 2018 | 3 | 0.140 |
Why?
| | Solubility | 1 | 2018 | 245 | 0.140 |
Why?
| | Interleukin-2 | 1 | 2018 | 453 | 0.130 |
Why?
| | Survival Analysis | 1 | 2019 | 1319 | 0.120 |
Why?
| | Apoptosis | 1 | 2025 | 2574 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2019 | 792 | 0.120 |
Why?
| | Immunity, Innate | 2 | 2020 | 852 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2016 | 223 | 0.120 |
Why?
| | Coculture Techniques | 1 | 2016 | 245 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 264 | 0.120 |
Why?
| | Dendritic Cells | 1 | 2018 | 505 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1491 | 0.110 |
Why?
| | Mice, Transgenic | 1 | 2019 | 2180 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 855 | 0.100 |
Why?
| | Serum Bactericidal Antibody Assay | 1 | 2013 | 1 | 0.100 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 11 | 0.100 |
Why?
| | Female | 5 | 2024 | 75515 | 0.100 |
Why?
| | Binding Sites, Antibody | 1 | 2012 | 42 | 0.090 |
Why?
| | Lymphocyte Activation | 1 | 2016 | 1150 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2560 | 0.090 |
Why?
| | DNA, Bacterial | 1 | 2013 | 339 | 0.090 |
Why?
| | Blood Bactericidal Activity | 1 | 2011 | 41 | 0.090 |
Why?
| | Mice, SCID | 1 | 2012 | 367 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 725 | 0.080 |
Why?
| | Genes, Bacterial | 1 | 2011 | 166 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 824 | 0.080 |
Why?
| | Signal Transduction | 2 | 2025 | 5144 | 0.080 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1274 | 0.070 |
Why?
| | Cell Membrane | 1 | 2012 | 724 | 0.070 |
Why?
| | Inflammation | 1 | 2018 | 2890 | 0.070 |
Why?
| | bcl-X Protein | 1 | 2025 | 43 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 3004 | 0.060 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2025 | 40 | 0.060 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 16 | 0.060 |
Why?
| | Male | 3 | 2020 | 69783 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2025 | 199 | 0.050 |
Why?
| | MAP Kinase Signaling System | 1 | 2025 | 325 | 0.050 |
Why?
| | Phosphorylation | 1 | 2025 | 1768 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 58 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 82 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2025 | 1330 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 151 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3469 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 180 | 0.030 |
Why?
| | Feces | 1 | 2018 | 504 | 0.030 |
Why?
| | Mutation | 1 | 2025 | 4013 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 521 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 631 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 785 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1819 | 0.020 |
Why?
| | Genetic Variation | 1 | 2011 | 1000 | 0.010 |
Why?
| | Pregnancy | 1 | 2018 | 7070 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9818 | 0.010 |
Why?
|
|
Clark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|